|
⚲
|
| Keyboard |
| Baumal Caroline
✚
|
|
|---|---|
| CIK # | 0001961100 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001961100] | |
| 4 | [0001961100] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Baumal Caroline | |
| Apellis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-22 | Sell | 2,797 | $21.77 | 60,891 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-20 | Sell | 1,882 | $19.79 | 37,245 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-05 | Sell | 3,020 | $25.53 | 77,101 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Grant | 82,500 | $19.39 | 1,599,675 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-21 | Grant | 39,594 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-17 | Sell | 1,853 | $29.96 | 55,516 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-06 | Sell | 2,816 | $33.81 | 95,209 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-01-16 | Grant | 37,000 | $66.30 | 2,453,100 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-16 | Grant | 25,445 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-04 | Sell | 2,751 | $60.05 | 165,198 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Grant | 49,000 | $50.28 | 2,463,720 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-01-03 | Grant | 35,549 | $0.00 |